< Back to catalogue
Alvoda®
July 14, 2026Arezil® XR
July 14, 2026PHARMAZAC
Aregalu®
Teriflunomide | Pyrimidine synthesis inhibitor | CNS
| AREGALU® F.C.TAB 14MG/TAB BT x 28 |
| AREGALU® F.C.TAB 14MG/TAB BT x 28 |
| BUSINESS UNIT | |
|---|---|
| MARKETING AUTHORISATION HOLDER | |
| PHARMACOLOGICAL CLASS | |
| PRESCRIPTION REQUIREMENT | |
| THERAPEUTIC AREA | |
| ACTIVE SUBSTANCE |
